Skip to main content
SpringerLink
Log in

Low risk of coronary artery disease in patients with acromegaly

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

The aims of this study are to determine the prevalence of coronary atherosclerosis in acromegalic patients and to investigate the relationship between the coronary artery calcium score (CS) and acromegaly status and clinical parameters [Framingham risk score (FRS)]. Fifty-six acromegalic patients and paired non-acromegalic volunteers were stratified according to the FRS into low-, intermediate-, and high-risk groups. CS was assessed using multidetector computed tomography. The patients were considered to have controlled or active acromegaly at the time they were submitted to evaluation. Sixty-six percent of acromegalic patients exhibited arterial hypertension, 36 % had diabetes mellitus, and 34 % had hypercholesterolemia. The median FRS and the median risk for cardiovascular event within the next 10 years were similar in the acromegalics and the controls. The median total CS and CS >75th percentile didn’t differ significantly between these groups. In patients with controlled acromegaly, a low, intermediate, or high FRS risk was observed in 86, 14, and 0 %, respectively. In patients with active disease, a low, intermediate, or high FRS risk was verified in 94, 3, and 3 %, respectively, and differences between the controlled and active groups were not significant. Seventy-two percent of the patients had total CS = 0, and there were no differences between the controlled and active groups. The risk of coronary artery disease in acromegalic patients, determined according to FRS and CS, is low despite the high prevalence of metabolic abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr. Rev. 25(1), 102–152 (2004). doi:10.1210/er.2002-0022

    Article  CAS  PubMed  Google Scholar 

  2. I.M. Holdaway, M.J. Bolland, G.D. Gamble, A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur. J. Endocrinol. 159(2), 89–95 (2008). doi:10.1530/EJE-08-0267

    Article  CAS  PubMed  Google Scholar 

  3. O.M. Dekkers, N.R. Biermasz, A.M. Pereira, J.A. Romijn, J.P. Vandenbroucke, Mortality in acromegaly: a metaanalysis. J. Clin. Endocrinol. Metab. 93(1), 61–67 (2008). doi:10.1210/jc.2007-1191

    Article  CAS  PubMed  Google Scholar 

  4. G. Brevetti, P. Marzullo, A. Silvestro, R. Pivonello, G. Oliva, C. di Somma, G. Lombardi, A. Colao, Early vascular alterations in acromegaly. J. Clin. Endocrinol. Metab. 87(7), 3174–3179 (2002). doi:10.1210/jcem.87.7.8643

    Article  CAS  PubMed  Google Scholar 

  5. I. Kartal, H. Oflaz, B. Pamukcu, M. Meric, F. Aral, N. Ozbey, F. Alagol, Investigation of early atherosclerotic changes in acromegalic patients. Int. J. Clin. Pract. 64(1), 39–44 (2010). doi:10.1111/j.1742-1241.2008.01750.x

    Article  CAS  PubMed  Google Scholar 

  6. L. Sacca, A. Cittadini, S. Fazio, Growth hormone and the heart. Endocr. Rev. 15(5), 555–573 (1994). doi:10.1210/edrv-15-5-555

    Article  CAS  PubMed  Google Scholar 

  7. R.N. Clayton, Cardiovascular function in acromegaly. Endocr. Rev. 24(3), 272–277 (2003). doi:10.1210/er.2003-0009

    Article  CAS  PubMed  Google Scholar 

  8. A.F. Casini, P.B. Araujo, R. Fontes, S.S. Xavier, M.R. Gadelha, Cardiac morphology and performance alterations and analysis of determinant factors of left ventricular hypertrophy in 40 patients with acromegaly. Arq. Bras. Endocrinol. Metabol. 50(1), 82–90 (2006). doi:10.1590/S0004-27302006000100012

    Article  PubMed  Google Scholar 

  9. S. Cannavo, B. Almoto, G. Cavalli, S. Squadrito, G. Romanello, M.T. Vigo, F. Fiumara, S. Benvenga, F. Trimarchi, Acromegaly and coronary disease: an integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography. J. Clin. Endocrinol. Metab. 91(10), 3766–3772 (2006). doi:10.1210/jc.2005-2857

    Article  CAS  PubMed  Google Scholar 

  10. F. Bogazzi, L. Battolla, C. Spinelli, G. Rossi, S. Gavioli, V. Di Bello, C. Cosci, C. Sardella, D. Volterrani, E. Talini, P. Pepe, F. Falaschi, G. Mariani, E. Martino, Risk factors for development of coronary heart disease in patients with acromegaly: a five-year prospective study. J. Clin. Endocrinol. Metab. 92(11), 4271–4277 (2007). doi:10.1210/jc.2007-1213

    Article  CAS  PubMed  Google Scholar 

  11. R.B. D’Agostino Sr, S. Grundy, L.M. Sullivan, P. Wilson, C.H.D.R.P. Group, Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286(2), 180–187 (2001)

    Article  PubMed  Google Scholar 

  12. P. Greenland, L. LaBree, S.P. Azen, T.M. Doherty, R.C. Detrano, Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291(2), 210–215 (2004). doi:10.1001/jama.291.2.210

    Article  CAS  PubMed  Google Scholar 

  13. M.J. Budoff, K. Nasir, R.L. McClelland, R. Detrano, N. Wong, R.S. Blumenthal, G. Kondos, R.A. Kronmal, Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (multi-ethnic study of atherosclerosis). J. Am. Coll. Cardiol. 53(4), 345–352 (2009). doi:10.1016/j.jacc.2008.07.072

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. R. Detrano, A.D. Guerci, J.J. Carr, D.E. Bild, G. Burke, A.R. Folsom, K. Liu, S. Shea, M. Szklo, D.A. Bluemke, D.H. O’Leary, R. Tracy, K. Watson, N.D. Wong, R.A. Kronmal, Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N. Engl. J. Med. 358(13), 1336–1345 (2008). doi:10.1056/NEJMoa072100

    Article  CAS  PubMed  Google Scholar 

  15. A.J. Taylor, J. Bindeman, I. Feuerstein, F. Cao, M. Brazaitis, P.G. O’Malley, Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J. Am. Coll. Cardiol. 46(5), 807–814 (2005). doi:10.1016/j.jacc.2005.05.049

    Article  CAS  PubMed  Google Scholar 

  16. J.T. Lie, Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am. Heart J. 100(1), 41–52 (1980)

    Article  CAS  PubMed  Google Scholar 

  17. H. Akutsu, J. Kreutzer, G. Wasmeier, D. Ropers, C. Rost, M. Mohlig, H. Wallaschofski, M. Buchfelder, C. Schofl, Acromegaly per se does not increase the risk for coronary artery disease. Eur. J. Endocrinol. 162(5), 879–886 (2010). doi:10.1530/EJE-09-0945

    Article  CAS  PubMed  Google Scholar 

  18. B.L. Herrmann, M. Severing, A. Schmermund, C. Berg, T. Budde, R. Erbel, K. Mann, Impact of disease duration on coronary calcification in patients with acromegaly. Exp. Clin. Endocrinol. Diabetes 117(8), 417–422 (2009). doi:10.1055/s-0029-1214386

    Article  CAS  PubMed  Google Scholar 

  19. M. Ragonese, A. Alibrandi, G. Di Bella, I. Salamone, S. Puglisi, O.R. Cotta, M.L. Torre, F. Ferrau, R.M. Ruggeri, F. Trimarchi, S. Cannavo, Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. Endocrine 47(1), 206–212 (2014). doi:10.1007/s12020-013-0115-8

    CAS  PubMed  Google Scholar 

  20. M. Otsuki, S. Kasayama, H. Yamamoto, H. Saito, S. Sumitani, H. Kouhara, Y. Saitoh, T. Ohnishi, N. Arita, Characterization of premature atherosclerosis of carotid arteries in acromegalic patients. Clin. Endocrinol. 54(6), 791–796 (2001)

    Article  CAS  Google Scholar 

  21. World Health Organization, Guidelines for the conduct of tobacco smoking among health professionals (Report WHO Meeting, Winnipeg, Canadá, 1983)

    Google Scholar 

  22. World Health Organization, Obesity: preventing and managing the global epidemic (Report of a WHO Consultation, Geneva, 2000)

    Google Scholar 

  23. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer Jr, L.T. Clark, D.B. Hunninghake, R.C. Pasternak, S.C. Smith Jr, N.J. Stone, National Heart, Lung and Blood Institute, American College of Cardiology Foundation, American Heart Association, Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110(2), 227–239 (2004). doi:10.1161/01.CIR.0000133317.49796.0E

    Article  PubMed  Google Scholar 

  24. A.S. Agatston, W.R. Janowitz, F.J. Hildner, N.R. Zusmer, M. Viamonte Jr, R. Detrano, Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15(4), 827–832 (1990)

    Article  CAS  PubMed  Google Scholar 

  25. I. Gottlieb, L. Sara, J.A. Brinker, J.A. Lima, C.E. Rochitte, CT coronary calcification: What does a score of “0” mean? Curr. Cardiol. Rep. 13(1), 49–56 (2011). doi:10.1007/s11886-010-0151-4

    Article  PubMed  Google Scholar 

  26. R.L. McClelland, K. Nasir, M. Budoff, R.S. Blumenthal, R.A. Kronmal, Arterial age as a function of coronary artery calcium (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am. J. Cardiol. 103(1), 59–63 (2009). doi:10.1016/j.amjcard.2008.08.031

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. M. Fleseriu, Insight into cardiovascular risk factors in patients with acromegaly. Endocrine 47(1), 1–2 (2014). doi:10.1007/s12020-013-0157-y

    Article  CAS  PubMed  Google Scholar 

  28. C. Berg, S. Petersenn, H. Lahner, B.L. Herrmann, M. Buchfelder, M. Droste, G.K. Stalla, C.J. Strasburger, U. Roggenbuck, N. Lehmann, S. Moebus, K.H. Jockel, S. Mohlenkamp, R. Erbel, B. Saller, K. Mann, Investigative Group of the Heinz Nixdorf Recall Study and the German Pegvisomant Observational Study Board and Investigators, Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control. J. Clin. Endocrinol. Metab. 95(8), 3648–3656 (2010). doi:10.1210/jc.2009-2570

    Article  CAS  PubMed  Google Scholar 

  29. L. Katznelson, Alterations in body composition in acromegaly. Pituitary 12(2), 136–142 (2009). doi:10.1007/s11102-008-0104-8

    Article  CAS  PubMed  Google Scholar 

  30. S. Cannavo, F. Marini, L. Curto, M.L. Torre, C. de Gregorio, I. Salamone, A. Alibrandi, F. Trimarchi, High prevalence of coronary calcifications and increased risk for coronary heart disease in adults with growth hormone deficiency. J. Endocrinol. Invest. 34(1), 32–37 (2011). doi:10.3275/7076

    Article  CAS  PubMed  Google Scholar 

  31. P. Delafontaine, H. Lou, R.W. Alexander, Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells. Hypertension 18(6), 742–747 (1991)

    Article  CAS  PubMed  Google Scholar 

  32. A. Juul, T. Scheike, M. Davidsen, J. Gyllenborg, T. Jorgensen, Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106(8), 939–944 (2002)

    Article  CAS  PubMed  Google Scholar 

  33. E. Conti, C. Carrozza, E. Capoluongo, M. Volpe, F. Crea, C. Zuppi, F. Andreotti, Insulin-like growth factor-1 as a vascular protective factor. Circulation 110(15), 2260–2265 (2004). doi:10.1161/01.CIR.0000144309.87183.FB

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Author notes

    Authors and Affiliations

    1. Neuroendocrinology Research Center/Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho – Universidade Federal do Rio de Janeiro, Rua Prof. Rodolpho Paulo Rocco, 255, 9th floor, Ilha do Fundão, Rio de Janeiro, 21941-913, Brazil

      Cintia Marques dos Santos Silva, L. Kasuki, L. Vieira Neto & M. R. Gadelha

    2. Endocrinology Section, Medical School and Hospital Universitário Antônio Pedro – Universidade Federal Fluminense, Niterói, Brazil

      G. A. B. Lima

    3. Cardiology Section, Medical School and Hospital Universitário Clementino Fraga Filho – Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

      I. C. M. Volschan

    4. Clínica de Diagnóstico por Imagem/Multi-Imagem, Rio de Janeiro, Brazil

      I. Gottlieb

    5. Endocrinology Section, Hospital Federal de Bonsucesso, Rio de Janeiro, Brazil

      L. Kasuki

    6. Endocrinology Section, Hospital Federal da Lagoa, Rio de Janeiro, Brazil

      L. Vieira Neto

    Authors
    1. Cintia Marques dos Santos Silva
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. G. A. B. Lima
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. I. C. M. Volschan
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. I. Gottlieb
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. L. Kasuki
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. L. Vieira Neto
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. M. R. Gadelha
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Cintia Marques dos Santos Silva.

    Additional information

    Cintia Marques dos Santos Silva and G. A. B. Lima have equally contributed to the development of the research and this paper.

    Electronic supplementary material

    Below is the link to the electronic supplementary material.

    Supplementary material 1 (DOCX 16 kb)

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    dos Santos Silva, C.M., Lima, G.A.B., Volschan, I.C.M. et al. Low risk of coronary artery disease in patients with acromegaly. Endocrine 50, 749–755 (2015). https://doi.org/10.1007/s12020-015-0628-4

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s12020-015-0628-4

    Keywords

    Search

    Navigation